Qiming Venture Partners and Portfolio Companies' Female Leaders Win Over 10 Awards
The list and its curation aim to celebrate women's contributions and achievements in China's equity investment sector and to the Chinese economy.
Recently, media outlets and institutions released rankings and special features spotlighting women on the front lines of venture capital and outstanding women in business, celebrating women's contributions and achievements in China's equity investment sector and the broader economy.
Qiming Venture Partners Partner Wang Xin, Partner and RMB Fund General Manager Jia Yu, and Executive Director Liu Xingdi received multiple honors. Wang Xin was named to PEDaily's S50 2025 Women's Day special feature, Touzijia's list of 38 Best Female Investors, and Rongzi China's 2024 Best Female Investors in China. Jia Yu was recognized as Best Female IR by China FOF Research Center. Liu Xingdi was recognized as Most Promising Female Direct Investment Fund Investor.
Wang Xin, Partner, Qiming Venture Partners
Named to
PEDaily S50 2025 Women's Day Special Feature
Zero2IPO's PEDaily turned its attention to women on the investment front lines for its S50 Women's Day special feature. Here, S stands for She — the steel roses; for Super, representing superpowers; for Smart, reflecting their intellectual firepower; and for Shining, highlighting their professionalism.
Jia Yu, Partner and RMB Fund General Manager, Qiming Venture Partners
Recognized as
Best Female IR
Liu Xingdi, Executive Director, Qiming Venture Partners
Recognized as
Most Promising Female Direct Investment Fund Investor
Drawing on its data and research analysis, China FOF Research Center officially released its 2025 Outstanding Female Professionals series to celebrate excellence among women in private equity fund-of-funds and fund management, and to promote the healthy development of the equity investment industry.
Wang Xin, Partner, Qiming Venture Partners
Named to
Touzijia's List of 38 Best Female Investors
To honor women investors who have worked diligently and achieved results in the VC/PE industry, Touzijia and its research institute released the 2025 list of 38 Best Female Investors, aiming to inspire women who continue to drive healthy development of the VC/PE ecosystem and bring vitality to the new economy.
Wang Xin, Partner, Qiming Venture Partners
Recognized as
Rongzi China 2024 Best Female Investor in China
To promote healthy development of the equity investment industry and celebrate the contributions and achievements of women investors, Rongzi China Research selected the 2024 Best Female Investors in China based on database records, survey responses, and criteria including education, professional experience, and track record.
Walter Cao, co-founder and general manager of Qiming portfolio company Tigermed (300347.SZ, 03347.HK); Li Ni, vice chairwoman and chief operating officer of Bilibili (NASDAQ:BILI, 09626.HK); Samantha Du, founder, chairwoman, and CEO of Zai Lab (NASDAQ:ZLAB, 09688.HK); Haoying Shi, founder and CEO of SinoUnited Health; and Qiu Xiaoxin, founder and chairwoman of Axera, were named to the 2025 Forbes China 100 Outstanding Businesswomen list.
Zoe Ng, founder and co-CEO of moodytiger, and Zhang Hui, founder and CEO of Intuitive Surgical China (Yingtukang), were named to the 2025 Forbes China 20 Promising Businesswomen list.
Walter Cao, co-founder and general manager, Tigermed Li Ni, vice chairwoman and chief operating officer, Bilibili Samantha Du, founder, chairwoman, and CEO, Zai Lab Haoying Shi, founder and CEO, SinoUnited Health Qiu Xiaoxin, founder and chairwoman, Axera Named to 2025 Forbes China 100 Outstanding Businesswomen
Zoe Ng, founder and co-CEO, moodytiger
(Zoe Ng)
Zhang Hui, founder and CEO, Yingtukang
Named to 2025 Forbes China 20 Promising Businesswomen
Forbes China published its 11th annual 100 Outstanding Businesswomen list. This year, the research focused on female executives at Chinese listed companies, women leaders of multinational corporations in China, and female founders of unicorn companies, analyzing data on business performance, capital market performance, market scale, industry influence, and innovation.
The Forbes China 20 Promising Businesswomen list aims to showcase female entrepreneurs who have demonstrated resilient growth amid adversity, using their extraordinary courage and wisdom as inspiration for more women to step forward, inject new vitality into the business world, and become indispensable forces in this era.
Source | Compiled from PEDaily, China FOF Research Center, Touzijia, Rongzi China, Forbes China
PAST HIGHLIGHTS
Qiming Venture Partners was founded in 2006. The firm currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since its inception, Qiming has focused on investing in early- and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), APT Medical (688617.SH), NuoHui Health (06606.HK), Sanyou Medical (688085.SH), AmoyDx (300685.SZ), Berry Genomics (000710.SZ), Sinocelltech (688520.SH), Yuanxin Technology, Caidya, Belief BioMed, and Biren Technology.